HK Stock Market Move | Goldwind Science & Technology (02208) rose over 13% in early trading. The process of the commercial rocket company's IPO may be accelerated. The company holds a 8.3% stake in Blue Sword Aerospace.

Goldwind Science & Technology (02208) rose more than 13% in early trading, rising 13.25% to HK$15.14 as of the time of writing, with a turnover of HK$539 million. On the news front, on December 26th, the Shanghai Stock Exchange issued detailed rules for the fifth set of listing standards applicable to commercial rocket companies on the Sci-Tech Innovation Board, marking the official opening of the channel for commercial rocket companies to enter the capital market with clear standards. a CITIC SEC research report stated that under the emphasis on policies related to "undertaking national tasks, participating in national engineering projects," "reusable technology," and "industry status," the IPO process of leading private commercial rocket companies may accelerate. According to the 2023 annual report of Goldwind Science & Technology, the company holds an 8.3% stake in Blue Arrow Aerospace Technology Co., Ltd. Public information shows that Blue Arrow Aerospace was established in 2015 and is one of the first private commercial rocket companies in China. In 2023, its Zhuque-2 Y-2 rocket successfully entered orbit, becoming the world's first liquid methane rocket to achieve orbit. From October 18th to 20th, 2025, the Zhuque-3 Y-1 rocket completed the first stage of the maiden flight mission and static ignition test in the Dongfeng Commercial Aerospace Innovation Test Area.